BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30582694)

  • 1. Kinetic Analyses of the Siderophore Biosynthesis Inhibitor Salicyl-AMS and Analogues as MbtA Inhibitors and Antimycobacterial Agents.
    Bythrow GV; Mohandas P; Guney T; Standke LC; Germain GA; Lu X; Ji C; Levendosky K; Chavadi SS; Tan DS; Quadri LEN
    Biochemistry; 2019 Feb; 58(6):833-847. PubMed ID: 30582694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: an adenylation enzyme required for siderophore biosynthesis of the mycobactins.
    Qiao C; Gupte A; Boshoff HI; Wilson DJ; Bennett EM; Somu RV; Barry CE; Aldrich CC
    J Med Chem; 2007 Nov; 50(24):6080-94. PubMed ID: 17967002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with nucleoside bisubstrate analogues: structure-activity relationships of the nucleobase domain of 5'-O-[N-(salicyl)sulfamoyl]adenosine.
    Neres J; Labello NP; Somu RV; Boshoff HI; Wilson DJ; Vannada J; Chen L; Barry CE; Bennett EM; Aldrich CC
    J Med Chem; 2008 Sep; 51(17):5349-70. PubMed ID: 18690677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a selective activity-based probe for adenylating enzymes: profiling MbtA Involved in siderophore biosynthesis from Mycobacterium tuberculosis.
    Duckworth BP; Wilson DJ; Nelson KM; Boshoff HI; Barry CE; Aldrich CC
    ACS Chem Biol; 2012 Oct; 7(10):1653-8. PubMed ID: 22796950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.
    Engelhart CA; Aldrich CC
    J Org Chem; 2013 Aug; 78(15):7470-81. PubMed ID: 23805993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aryl acid adenylating enzymes involved in siderophore biosynthesis: fluorescence polarization assay, ligand specificity, and discovery of non-nucleoside inhibitors via high-throughput screening.
    Neres J; Wilson DJ; Celia L; Beck BJ; Aldrich CC
    Biochemistry; 2008 Nov; 47(45):11735-49. PubMed ID: 18928302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Aryl-8-aza-3-deazaadenosine analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: Nucleoside antibiotics that block siderophore biosynthesis in Mycobacterium tuberculosis.
    Krajczyk A; Zeidler J; Januszczyk P; Dawadi S; Boshoff HI; Barry CE; Ostrowski T; Aldrich CC
    Bioorg Med Chem; 2016 Jul; 24(14):3133-43. PubMed ID: 27265685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated Target-Based and Phenotypic Screening Approaches for the Identification of Anti-Tubercular Agents That Bind to the Mycobacterial Adenylating Enzyme MbtA.
    Ferguson L; Wells G; Bhakta S; Johnson J; Guzman J; Parish T; Prentice RA; Brucoli F
    ChemMedChem; 2019 Oct; 14(19):1735-1741. PubMed ID: 31454170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.
    Gupte A; Boshoff HI; Wilson DJ; Neres J; Labello NP; Somu RV; Xing C; Barry CE; Aldrich CC
    J Med Chem; 2008 Dec; 51(23):7495-507. PubMed ID: 19053762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the structure of Mycobacterium tuberculosis MbtA: model validation using molecular dynamics simulations and docking studies.
    Maganti L; Open Source Drug Discovery Consortium ; Ghoshal N
    J Biomol Struct Dyn; 2014; 32(2):273-88. PubMed ID: 23527569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.
    Nelson KM; Viswanathan K; Dawadi S; Duckworth BP; Boshoff HI; Barry CE; Aldrich CC
    J Med Chem; 2015 Jul; 58(14):5459-75. PubMed ID: 26110337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain.
    Somu RV; Wilson DJ; Bennett EM; Boshoff HI; Celia L; Beck BJ; Barry CE; Aldrich CC
    J Med Chem; 2006 Dec; 49(26):7623-35. PubMed ID: 17181146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis.
    Dawadi S; Viswanathan K; Boshoff HI; Barry CE; Aldrich CC
    J Org Chem; 2015 May; 80(10):4835-50. PubMed ID: 25916415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative three dimensional structure linear interaction energy model of 5'-O-[N-(salicyl)sulfamoyl]adenosine and the aryl acid adenylating enzyme MbtA.
    Labello NP; Bennett EM; Ferguson DM; Aldrich CC
    J Med Chem; 2008 Nov; 51(22):7154-60. PubMed ID: 18959400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.
    Baran M; Grimes KD; Sibbald PA; Fu P; Boshoff HIM; Wilson DJ; Aldrich CC
    Eur J Med Chem; 2020 Sep; 201():112408. PubMed ID: 32574901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents.
    Vannada J; Bennett EM; Wilson DJ; Boshoff HI; Barry CE; Aldrich CC
    Org Lett; 2006 Oct; 8(21):4707-10. PubMed ID: 17020283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gram-scale preparation of the antibiotic lead compound salicyl-AMS, a potent inhibitor of bacterial salicylate adenylation enzymes.
    Kinarivala N; Standke LC; Guney T; Ji C; Noguchi N; Asano Y; Tan DS
    Methods Enzymol; 2020; 638():69-87. PubMed ID: 32416922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic and inhibition studies of dihydroxybenzoate-AMP ligase from Escherichia coli.
    Sikora AL; Wilson DJ; Aldrich CC; Blanchard JS
    Biochemistry; 2010 May; 49(17):3648-57. PubMed ID: 20359185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D-QSAR studies and shape based virtual screening for identification of novel hits to inhibit MbtA in Mycobacterium tuberculosis.
    Maganti L; ; Ghoshal N
    J Biomol Struct Dyn; 2015; 33(2):344-64. PubMed ID: 24417439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abyssomicin C family as in vitro inhibitors of Mycobacterium tuberculosis.
    Freundlich JS; Lalgondar M; Wei JR; Swanson S; Sorensen EJ; Rubin EJ; Sacchettini JC
    Tuberculosis (Edinb); 2010 Sep; 90(5):298-300. PubMed ID: 20739223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.